Quickstart Highlights

This blend combines two well-studied regenerative peptides: BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from human gastric juice with cytoprotective and wound-healing properties^[1][2], and TB-500 (Thymosin Beta-4 fragment), a 43-amino-acid peptide involved in tissue repair, cell migration, and angiogenesis^[3][4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

• Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL total concentration (1.67 mg/mL of each peptide).
• Typical daily range: 600–1000 mcg total blend once daily (provides 300–500 mcg of each peptide).
• Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg total blend on a U-100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Protocol Overview

Concise summary of the once-daily regimen.

• Goal: Support tissue repair, wound healing, and recovery from musculoskeletal injuries^[1][3].
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if needed).
• Dose Range: 600–1000 mcg total blend daily (300–500 mcg of each peptide).
• Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily phased approach.

• Start: 600 mcg total daily (300 mcg each peptide) for Weeks 1–2.
• Loading: Increase to 800 mcg daily for Weeks 3–4.
• Maintenance: Return to 600 mcg daily for Weeks 5–8+.
• Frequency: Once per day (subcutaneous).
• Cycle Length: 8–12 weeks; optional extension to 16 weeks.

Storage Instructions

Proper storage preserves peptide quality and stability.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 4–6 weeks; avoid freeze–thaw.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Both peptides are not approved for routine human use (sold for research purposes) and are banned in competitive sports^[10].
• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation^[7].
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.

How This Works

BPC-157 is a stable pentadecapeptide that promotes angiogenesis, modulates nitric oxide pathways, and demonstrates broad cytoprotective effects across gastrointestinal, musculoskeletal, and neurological tissues in preclinical models^[1][2]. It has shown activity at very low doses (nanogram to microgram per kilogram) without demonstrable toxicity in animal studies^[11].

TB-500 (Thymosin Beta-4) is an actin-sequestering peptide that promotes cell migration, wound healing, and anti-inflammatory responses^[3][4]. It is well-tolerated in animal and early clinical studies, even at multi-milligram doses^[12].

Combining these peptides may provide complementary mechanisms for tissue repair: BPC-157 for its trophic and anti-inflammatory effects, and TB-500 for enhanced cell migration and angiogenesis^[8].

Potential Benefits & Side Effects

Observations from preclinical and limited clinical literature.

• May support accelerated healing of tendons, ligaments, muscles, and soft tissue injuries^[1][5].
• Preclinical evidence suggests gastroprotective and anti-inflammatory properties for BPC-157^[2].
• TB-500 promotes wound healing and may reduce scarring through enhanced cell migration^[3].
• Both peptides are generally well tolerated; occasional mild injection-site reactions (redness, itching) may occur with subcutaneous administration.
• No significant toxicity has been documented up to high doses in animal studies^[11][12].

Lifestyle Factors

Complementary strategies for optimal recovery outcomes.

• Prioritize adequate protein intake (1.6–2.2 g/kg body weight) to support tissue repair.
• Follow appropriate rehabilitation protocols for any injuries being addressed.
• Ensure adequate sleep (7–9 hours) to optimize recovery and tissue regeneration.
• Manage inflammation through balanced nutrition and stress reduction techniques.

Injection Technique

General subcutaneous guidance from clinical best-practice resources^[6][7].

• Clean the vial stopper and skin with alcohol; allow to dry completely.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue^[13].
• Do not aspirate for subcutaneous injections; inject slowly and steadily^[13].
• Rotate sites systematically (abdomen at least 2 inches from navel, thighs, upper arms, flank) to avoid lipohypertrophy^[7].
• Apply gentle pressure post-injection; do not rub the site.

Recommended Source

We recommend Pure Lab Peptides for high-purity BPC-157 + TB-500 (20 mg Blend).

Shop at Pure Lab Peptides

References